cart-psma-tgfbetardn cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 8, 2017 (NCT03089203)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Glutamate carboxypeptidase IIImmunity, passive
FOLH1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cart-psma-tgfbetardn cells
- cart-psma-tgfβrdn cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04227275 | Phase 1 | Nov 22, 2019 | Tmunity Therapeutics |
| NCT03089203 | Phase 1 | Mar 8, 2017 | University of Pennsylvania |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tmunity Therapeutics | For profit | 1 | 1 | 1 | 2019 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1